122 related articles for article (PubMed ID: 26406255)
1. Saatchi's Medical Innovation Bill: progressive, unnecessary or dangerous?
Bolton H
BJOG; 2015 Oct; 122(11):1436. PubMed ID: 26406255
[No Abstract] [Full Text] [Related]
2. Medical innovation does not require a new law.
Hallissey C
BJOG; 2015 Oct; 122(11):1435. PubMed ID: 26406254
[No Abstract] [Full Text] [Related]
3. Are rigid management protocols stifling innovation in cancer treatment?
Crosbie EJ; Edmondson RJ; McNeish IA; Sasieni P
BJOG; 2015 Oct; 122(11):1432-4. PubMed ID: 26032865
[No Abstract] [Full Text] [Related]
4. Quackery or quality: the ethicolegal basis for a legislative framework for medical innovation.
Samanta J; Samanta A
J Med Ethics; 2015 Jun; 41(6):474-7. PubMed ID: 25552664
[TBL] [Abstract][Full Text] [Related]
5. Medical Innovation Bill is fundamentally unworkable.
Miola J; Hills D
BMJ; 2015 Feb; 350():h1003. PubMed ID: 25711888
[No Abstract] [Full Text] [Related]
6. Future of Saatchi bill is uncertain after Liberal Democrats' veto.
Dyer C
BMJ; 2015 Mar; 350():h1196. PubMed ID: 25736416
[No Abstract] [Full Text] [Related]
7. Can Congress Get 'Right to Try' Right?
Kirkner RM
Manag Care; 2018 May; 27(5):10-11. PubMed ID: 29763399
[TBL] [Abstract][Full Text] [Related]
8. Access for the terminally ill to experimental medical innovations: a three-pronged threat.
Bender S; Flicker L; Rhodes R
Am J Bioeth; 2007 Oct; 7(10):3-6. PubMed ID: 17926208
[No Abstract] [Full Text] [Related]
9. Why there is no legal or medical justification for the Saatchi bill.
Raftery J; Newdick C
BMJ; 2014 May; 348():g3464. PubMed ID: 24865354
[No Abstract] [Full Text] [Related]
10. Controversial Saatchi bill passes report stage in House of Lords.
Dyer C
BMJ; 2014 Dec; 349():g7680. PubMed ID: 25512337
[No Abstract] [Full Text] [Related]
11. More than 100 cancer experts attack Saatchi bill as potentially dangerous.
Iacobucci G
BMJ; 2014 Nov; 349():g6794. PubMed ID: 25395504
[No Abstract] [Full Text] [Related]
12. Medical Negligence Determinations, the "Right to Try," and Expanded Access to Innovative Treatments.
Meyerson D
J Bioeth Inq; 2017 Sep; 14(3):385-400. PubMed ID: 28634770
[TBL] [Abstract][Full Text] [Related]
13. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
Ochs A
Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
[No Abstract] [Full Text] [Related]
14. Protecting intellectual property is vital for medical innovation, says UK report.
Wise J
BMJ; 2014 Jan; 348():g1238. PubMed ID: 24482538
[No Abstract] [Full Text] [Related]
15. Withdraw Saatchi's quackery bill.
McCartney M
BMJ; 2014 Apr; 348():g2974. PubMed ID: 24780239
[No Abstract] [Full Text] [Related]
16. Health Care Reform Bill H. R. 3200--America's Affordable Health Choices Act: what is missing?
George JC; Bass TA
JACC Cardiovasc Interv; 2009 Oct; 2(10):1028-30. PubMed ID: 19850266
[No Abstract] [Full Text] [Related]
17. Medical liability reform crisis 2008.
Weinstein SL
Clin Orthop Relat Res; 2009 Feb; 467(2):392-401. PubMed ID: 18989732
[TBL] [Abstract][Full Text] [Related]
18. Saatchi is right to promote medical innovation but his bill is wrong way to do it.
Baum M
BMJ; 2015 Feb; 350():h531. PubMed ID: 25652261
[No Abstract] [Full Text] [Related]
19. The "Saatchi bill" will allow responsible innovation in treatment.
Rawlins MD
BMJ; 2014 Apr; 348():g2771. PubMed ID: 24735990
[No Abstract] [Full Text] [Related]
20. The Patient's Bill of Rights: is the cure worse than the disease?
Bowlus B
Manag Care Interface; 2000 Oct; 13(10):71-2. PubMed ID: 11155649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
